SAN DIEGO--(BUSINESS WIRE)--bioTheranostics, a leading provider of molecular diagnostic solutions for cancer, today announced that Mayo Clinic and Mayo Medical Laboratories will offer the company’s CancerTYPE ID® molecular cancer classification test, as part of its surgical pathology consultants, to aid in the management of patients with metastatic cancer.
Help employers find you! Check out all the jobs and post your resume.
